A double-blind, placebo-controlled, randomized clinical trial showed that after 8 weeks of oral treatment with 500 mg quercetin or placebo in 88 MI patients, the serum total antioxidant capacity (TAC) of the quercetin group was significantly improved, while the inflammatory factor TNF-α was also significantly reduced (12). Here, TNF is linked to myocardial infarction.